A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) G01N 33/94 (2006.01)
Patent
CA 2551553
The present invention provides for methods of treating and preventing muscle atrophy, cardiac hypertrophy, heart failure and/or primary pulmonary hypertension linked to a family of serotonin receptors called 5-HT2 receptors. The present invention further demonstrates that modulators of 5-HT2 receptors can inhibit or treat muscle atrophy, heart failure, cardiac hypertrophy, and/or primary pulmonary hypertension.
La présente invention a trait à des procédés de traitement et de prévention d'atrophie musculaire, d'hypertrophie cardiaque, d'insuffisance cardiaque et/ou d'hypertension pulmonaire primaire liés à la famille des récepteurs de la sérotonine désignés récepteurs 5-HT2. La présente invention a également trait à des modulateurs de récepteurs 5-HT2 aptes à l'inhibition ou au traitement d'atrophie musculaire, d'hypertrophie cardiaque, d'insuffisance cardiaque et/ou d'hypertension pulmonaire primaire.
Bush Erik
Melvin Larry
Olson Eric
Bcf Llp
Board Of Regents The University Of Texas System
Myogen Inc.
LandOfFree
Modulation of 5-ht2 receptors as a treatment for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of 5-ht2 receptors as a treatment for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of 5-ht2 receptors as a treatment for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2028008